CVM Cel-Sci Corporation
$1.49▼ -1.97%
Healthcare
Other
Volume 98.5K
Avg Volume (10D) 122.6K
Key Metrics & Fundamentals
Market Cap
$26.21M
P/E Ratio
–
Div Yield
–%
52W Range
0.89 - 10.83
% vs 50 MA
8.82%
% vs 200 MA
-53.33%
RSI-14
50.1
MACD Histogram
-0.0100
Beta (1Y vs SPY)
1.63
Free Cash Flow
-$4.03M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$4.61M
COGS
–
Operating Exp
$5.56M
Operating Income
-$5.56M
EBIT
-$5.56M
Pretax Income
-$5.67M
Net Income
-$5.67M
EPS (Diluted)
-0.47
Price & Volume History
Loading chart…
Recent News
CEL-SCI Reports Fiscal Third Quarter 2026 Results
Business Wire · Aug 17, 2026 12:30 PM
Cel-Sci: Fiscal Q3 Earnings Snapshot
Associated Press · Aug 14, 2026 9:16 PM
CEL-SCI Study Published in Peer-Reviewed Oral Oncology Supports Multikine's Biomarker Strategy and Potential Overall Survival Benefit Ahead of Head and Neck Cancer Confirmatory Registration Study
Business Wire · Aug 4, 2026 12:00 PM
Leading Oncology Journal Accepts For Publication New CEL-SCI Multikine Phase 3 Data Demonstrating Overall Survival Benefit in Underserved Head and Neck Cancer Patients
Business Wire · Jul 30, 2026 12:31 PM
CEL-SCI to Launch FDA Registration-Enabling Phase 3 Confirmatory Study to Bring Multikine® to Market for Newly Diagnosed Head and Neck Cancer
Business Wire · Jul 13, 2026 12:00 PM
CEL-SCI and Saudi Amarox Hold Strategic Agreement Signing Ceremony at BIO 2026, Advancing U.S.–Saudi Cooperation in Cancer Care
Business Wire · Jun 24, 2026 12:00 PM
CEL-SCI Closes $2.5 Million Stock Offering
MT Newswires · Jun 16, 2026 8:09 PM
CEL-SCI Announces Closing of Offering
Business Wire · Jun 16, 2026 8:01 PM
CEL-SCI Advances Multikine® Immunotherapy for Head and Neck Cancer Through Dual U.S. Registration Study and Saudi Market Entry Strategy
Business Wire · Jun 16, 2026 12:00 PM
CVM Stock Sinks In Pre-Market Trading After Announcing Second Equity Raise For Its Cancer Drug In Just Over A Month
Stocktwits · Jun 15, 2026 11:12 AM
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See CVM's money flow as a full page
Social Sentiment
Avg +0.80 · 2 posts
TradeDiscussionDDEarn Solana rewards for holding & compounding (NFA)
r/wallstreetbets · Apr 23, 2025
The post highlights CVM's technology and positive returns, driving a bullish sentiment.
positive
+0.80
DDTradePriceTargetCel Sci CVM, Just Bought $13K Worth
r/wallstreetbets · Jul 17, 2024
The post expresses strong optimism about CVM's product and potential, using phrases like 'great management,' 'great product,' and 'tremendous potential'.
very_positive
+0.80
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.